GlassScriptPhysician profile
Larry J Shemen
NPI 1699878736
$15,679.41
in general payments reported to CMS, 2019-2025
18 companies · $6,740 in 2025
The $6,740 reported for 2025 was more than what 96% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $199 · 2021: $778 · 2022: $2,853 · 2023: $2,624 · 2024: $2,317 · 2025: $6,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,008 · Consulting Fee: $4,000 · Food and Beverage: $1,654 · Travel and Lodging: $18.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,007.74 |
| Consulting Fee | $4,000.00 |
| Food and Beverage | $1,654.39 |
| Travel and Lodging | $18.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $10,720.56 | 2023-2025 | Tisseel, Floseal |
| Medical Device Business Services, INC. | $2,238.60 | 2022 | |
| Genzyme Corporation | $565.37 | 2020-2025 | |
| Intersect Ent, INC. | $555.57 | 2019-2022 | |
| Ethicon US, LLC | $307.14 | 2021 | |
| Acclarent, INC | $245.21 | 2020-2022 | |
| Optinose US, INC. | $229.09 | 2019-2025 | |
| Amgen INC. | $197.93 | 2024-2025 | Tepezza |
| Regeneron Healthcare Solutions, INC. | $103.64 | 2020-2024 | Dupixent |
| Stryker Corporation | $103.14 | 2021-2023 | Xpress Ent Dilation System, Scopis Ent, Shaver System |
| Sanofi-Aventis U.S. LLC | $98.99 | 2023 | |
| Axogen | $93.51 | 2022-2025 | |
| Integra Lifesciences Corporation | $82.00 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Hikma Pharmaceuticals USA | $67.53 | 2024 | Ryaltris |
| Medtronic, INC. | $25.23 | 2023 | Sinuva |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $20.96 | 2020 | |
| Inspire Medical Systems, INC. | $13.06 | 2023 | Inspire |
| Medtronic USA, INC. | $11.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Shemen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.